FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2911895816> ?p ?o ?g. }

• W2911895816 abstract "Efficacy and toxic and side effects of pirarubicin combined with cytarabine and mitoxantrone combined with cytarabine on the treatment of initially treated acute myeloid leukemia (AML) were compared. A retrospective analysis was performed on the medical records of 76 AML patients who were initially treated in Weifang People's Hospital. Among them, 36 patients (observation group) were treated with pirarubicin combined with cytarabine, and 40 patients (control group) were treated with mitoxantrone combined with cytarabine. The efficacy and toxic and side effects on patients in the two groups were observed. There was no statistically significant difference in the complete response (CR) rate, partial response (PR) rate and overall response (OR) rate of patients between the two groups (P>0.05). Patients in the observation group had significantly lower incidence of cardiotoxicity and alopecia than those in the control group (P<0.05). Patients in the observation group had lower incidence of bone marrow depression (BMD) at grade IV than those in the control group (P<0.05). The median progression‑free survival time of patients was 14.5 months in the observation group and 18 months in the control group. The progression‑free survival rate of patients was 36.11% in the observation group and 40.00% in the control group, with no difference between the two groups (P>0.05). The median survival time of patients was 22.5 months in the observation group and 24.5 months in the control group. The overall survival (OS) rate of patients was 44.44% in the observation group and 47.50% in the control group, with no difference between the two groups (P>0.05). Both pirarubicin combined with cytarabine and mitoxantrone combined with cytarabine have satisfactory efficacy on initially treated AML. Compared to the latter, the former has lower toxic and side effects." @default.
• W2911895816 created "2019-02-21" @default.
• W2911895816 creator A5002976448 @default.
• W2911895816 creator A5051298435 @default.
• W2911895816 creator A5066093471 @default.
• W2911895816 creator A5087099599 @default.
• W2911895816 date "2019-01-24" @default.
• W2911895816 modified "2023-09-26" @default.
• W2911895816 title "Observation of clinical efficacy and toxic and side effects of pirarubicin combined with cytarabine on acute myeloid leukemia" @default.
• W2911895816 cites W1559706597 @default.
• W2911895816 cites W1600188481 @default.
• W2911895816 cites W1964649928 @default.
• W2911895816 cites W1968076808 @default.
• W2911895816 cites W1970758655 @default.
• W2911895816 cites W1980796692 @default.
• W2911895816 cites W2008378325 @default.
• W2911895816 cites W2021009149 @default.
• W2911895816 cites W2024253505 @default.
• W2911895816 cites W2107075277 @default.
• W2911895816 cites W2153702401 @default.
• W2911895816 cites W2159317482 @default.
• W2911895816 cites W2161938647 @default.
• W2911895816 cites W2206373663 @default.
• W2911895816 cites W2288260164 @default.
• W2911895816 cites W2343567742 @default.
• W2911895816 cites W2398006306 @default.
• W2911895816 cites W2468368756 @default.
• W2911895816 cites W2473252551 @default.
• W2911895816 cites W2545842388 @default.
• W2911895816 cites W2560346983 @default.
• W2911895816 cites W2568445994 @default.
• W2911895816 cites W2580029370 @default.
• W2911895816 cites W2604113624 @default.
• W2911895816 cites W2611054855 @default.
• W2911895816 cites W2674609439 @default.
• W2911895816 cites W2761147299 @default.
• W2911895816 cites W2896584957 @default.
• W2911895816 cites W3024609366 @default.
• W2911895816 cites W3025872774 @default.
• W2911895816 cites W6531846 @default.
• W2911895816 doi "https://doi.org/10.3892/ol.2019.9966" @default.
• W2911895816 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6396216" @default.
• W2911895816 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30867778" @default.
• W2911895816 hasPublicationYear "2019" @default.
• W2911895816 type Work @default.
• W2911895816 sameAs 2911895816 @default.
• W2911895816 citedByCount "2" @default.
• W2911895816 countsByYear W29118958162021 @default.
• W2911895816 countsByYear W29118958162023 @default.
• W2911895816 crossrefType "journal-article" @default.
• W2911895816 hasAuthorship W2911895816A5002976448 @default.
• W2911895816 hasAuthorship W2911895816A5051298435 @default.
• W2911895816 hasAuthorship W2911895816A5066093471 @default.
• W2911895816 hasAuthorship W2911895816A5087099599 @default.
• W2911895816 hasBestOaLocation W29118958161 @default.
• W2911895816 hasConcept C120665830 @default.
• W2911895816 hasConcept C121332964 @default.
• W2911895816 hasConcept C126322002 @default.
• W2911895816 hasConcept C141071460 @default.
• W2911895816 hasConcept C2776085618 @default.
• W2911895816 hasConcept C2776283816 @default.
• W2911895816 hasConcept C2776581026 @default.
• W2911895816 hasConcept C2776694085 @default.
• W2911895816 hasConcept C2778041864 @default.
• W2911895816 hasConcept C2778461978 @default.
• W2911895816 hasConcept C2778729363 @default.
• W2911895816 hasConcept C2780923524 @default.
• W2911895816 hasConcept C61511704 @default.
• W2911895816 hasConcept C71924100 @default.
• W2911895816 hasConcept C90924648 @default.
• W2911895816 hasConceptScore W2911895816C120665830 @default.
• W2911895816 hasConceptScore W2911895816C121332964 @default.
• W2911895816 hasConceptScore W2911895816C126322002 @default.
• W2911895816 hasConceptScore W2911895816C141071460 @default.
• W2911895816 hasConceptScore W2911895816C2776085618 @default.
• W2911895816 hasConceptScore W2911895816C2776283816 @default.
• W2911895816 hasConceptScore W2911895816C2776581026 @default.
• W2911895816 hasConceptScore W2911895816C2776694085 @default.
• W2911895816 hasConceptScore W2911895816C2778041864 @default.
• W2911895816 hasConceptScore W2911895816C2778461978 @default.
• W2911895816 hasConceptScore W2911895816C2778729363 @default.
• W2911895816 hasConceptScore W2911895816C2780923524 @default.
• W2911895816 hasConceptScore W2911895816C61511704 @default.
• W2911895816 hasConceptScore W2911895816C71924100 @default.
• W2911895816 hasConceptScore W2911895816C90924648 @default.
• W2911895816 hasLocation W29118958161 @default.
• W2911895816 hasLocation W29118958162 @default.
• W2911895816 hasLocation W29118958163 @default.
• W2911895816 hasLocation W29118958164 @default.
• W2911895816 hasOpenAccess W2911895816 @default.
• W2911895816 hasPrimaryLocation W29118958161 @default.
• W2911895816 hasRelatedWork W1966099453 @default.
• W2911895816 hasRelatedWork W1989197571 @default.
• W2911895816 hasRelatedWork W2023291141 @default.
• W2911895816 hasRelatedWork W2030418865 @default.
• W2911895816 hasRelatedWork W2378816684 @default.
• W2911895816 hasRelatedWork W2383678627 @default.
• W2911895816 hasRelatedWork W2388486537 @default.
• W2911895816 hasRelatedWork W2389211016 @default.
• W2911895816 hasRelatedWork W2390728050 @default.

• next